4559 JPX Week ended 07 Aug 2026

Weekly Investor Report

Zeria Pharmaceutical Co., Ltd. · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data
Latest close 2,035 JPY
-2.6% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -5.5% below the Trend Line and sits at 30.9% of its 52-week range. The latest completed week returned -2.6%, after a -2.2% four-week move. The latest news-sentiment score is 55/100.

Setup score 46 out of 100
Latest Close 2,035 JPY 7 Aug 2026
1W Return -2.6% latest completed week
4W Return -2.2% short-term follow-through
12W Return -13.4% quarterly tape
Trend Breadth 44.2% 23 of 52 weeks active
Volume Ratio 2.1x vs 13-week average
What is working
  • Volume is elevated versus the 13-week average, confirming attention.
  • Next-week expectancy is positive at 57.09% based on similar historical setup states.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.6% Latest completed week; four-week move -2.2%. Indicator stack 24/39 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 57.09% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 55/100 5 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -5.5% below the Trend Line and sits at 30.9% of its 52-week range. The latest completed week returned -2.6%, after a -2.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 2.1x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2912-week average 0.59

12-week confirmation

Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.29Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -2.2% over four weeks, -13.4% over 12 weeks, and 2.9% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-2.6%
4W-2.2%
12W-13.4%
26W-4.2%
52W2.9%
Active trend streak0 weeks
Active weeks in one year23
Trend breadth44.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.76Latest activity-pressure read.
Pressure change36.6%Four-week change in activity pressure.
Leadership-19.46Latest relative-leadership reading.
RS change18.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment55/100

Weighted news tone is neutral across 5 relevant articles.

1 positive · 4 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-16.4%Distance below the 52-week high.
13-week volatility4.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+9.6%Week of 15 May.
Worst week-8.2%Week of 5 Jun.
Latest week-2.6%Week of 7 Aug.

Shape of recent returns

Strong gains2
Modest gains12
Flat weeks0
Modest losses9
Sharp losses3
Recent vol4.0%13-week weekly-return volatility.
Base vol3.0%52-week weekly-return volatility.
Up/down split27/24Count of positive and negative weeks in the 52-week window.
Average skew2.2% / -2.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape45/100

Trend, activity pressure, participation, and risk combine to a 45/100 tape read.

 Indicator analysis27/100

Latest 12-week confirmation: trend 4/12, activity pressure 3/12, relative leadership 0/12.

Activity pressure 0.29; No reversal markers Next-Week ExpectancyPositive 57.09%

Next-week expectancy is positive with a 57.09% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment55/100

Weighted news tone is neutral across 5 relevant articles.

Zeria Pharmaceutical lifts sales and maintains dividend as profits soften in Q1 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20262,035 JPY-2.6%2,152 JPY2,080 JPY-0.76-19.46687.8KOff
31 Jul 20262,090 JPY0.4%2,154 JPY2,082 JPY-0.83-16.37481.6KOff
24 Jul 20262,081 JPY1.3%2,154 JPY2,082 JPY-1.04-17.79302.8KOff
17 Jul 20262,054 JPY-1.2%2,154 JPY2,083 JPY-1.13-18.91311.3KOff
10 Jul 20262,080 JPY1.6%2,154 JPY2,084 JPY-1.20-23.87597.8KOff
3 Jul 20262,048 JPY0.5%2,150 JPY2,084 JPY-1.31-27.0362.3KOff
26 Jun 20262,038 JPY-0.5%2,146 JPY2,085 JPY-1.23-27.70137.3KOff
19 Jun 20262,049 JPY-4.4%2,146 JPY2,087 JPY-0.83-29.95119.2KOff
12 Jun 20262,143 JPY1.9%2,143 JPY2,089 JPY-0.32-21.7964.8KOn
5 Jun 20262,103 JPY-8.2%2,136 JPY2,091 JPY0.20-24.6158.3KOn
29 May 20262,292 JPY-3.7%2,130 JPY2,092 JPY0.31-18.32415.7KOn
22 May 20262,380 JPY1.3%2,119 JPY2,092 JPY0.16-12.04397.2KOn
15 May 20262,350 JPY9.6%2,106 JPY2,092 JPY0.12-11.16660.5KOn
8 May 20262,145 JPY0.6%2,093 JPY2,092 JPY0.22-21.20282.5KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context